1-20 of 38
Tommasina Guglielmelli
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Safety and Efficacy of New Drugs Combinations in Newly Diagnosed Multiple Myeloma with Renal Failure at Onset: A Retrospective Multicentric Study

Antonio Frolli, Claudio Cerchione, Riccardo Staiano, Tommasina Guglielmelli, Davide Nappi, Agnese Mattei, Silvia Marini, Daniela Cilloni, Guido Eugenio Parvis
Journal: Blood
Blood (2023) 142 (Supplement 1): 6656.
https://doi.org/10.1182/blood-2023-190212
Published: 2023
Journal Articles

Impact of Bortezomib- or Lenalidomide-Based Induction Treatment on High Risk Cytogenetic Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma Enrolled in the Gimema-MM-03-05 and EMN01 Trials

Alessandra Larocca, Massimo Offidani, MD, Pellegrino Musto, MD, Francesca Patriarca, MD, Lorenzo De Paoli, MD, Paolo Corradini, MD, Marco Salvini, MD, Clotilde Cangialosi, MD, Tommasina Guglielmelli, MD, Giovannino Ciccone, Fausto Dore, MD, Angelo Belotti, MD, Mattia D'Agostino, MD, Felicetto Ferrara, MD, Daniela Oddolo, Riccardo Centurioni, MD, Fabrizio Ciambelli, MD, Stefano Spada, Donatella Iolanda Vincelli, MD, Michele Cavo, MD, Nicola Giuliani, MD PhD, Alberto Bosi, MD, Concetta Conticello, MD, Roberto Ria, MD, Maria Teresa Petrucci, MD, Mario Boccadoro
Journal: Blood
Blood (2017) 130 (Supplement 1): 744.
https://doi.org/10.1182/blood.V130.Suppl_1.744.744
Published: 2017
Journal Articles

Impact of Treatment Intensification According to Patient Prognosis: A Pooled Analysis of 3 Randomized Phase III Trials

Francesca Gay, MD, Mattia D'Agostino, MD, Roman Hajek, prof, MD PhD, Sara Bringhen, MD, Concetta Conticello, MD, Gianluca Gaidano, MD PhD, Vittorio Montefusco, Sara Pezzatti, MD, Marco Salvini, MD, Tommaso Caravita, MD, Anna Maria Cafro, MD, Michele Cavo, MD, Marina Ruggeri, Fortunato Morabito, MD, Roberto Mina, MD, Luca Baldini, MD Prof, Giulia Benevolo, MD, Tommasina Guglielmelli, MD, Annalisa Bernardini, Roberto Foà, MD, Francesca Patriarca, MD, Massimo Offidani, MD, Roberto Ria, MD, Dina Ben Yehuda, MD, Maria Teresa Petrucci, MD, Andrew Spencer, MD, Antonio Palumbo, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2016) 128 (22): 995.
https://doi.org/10.1182/blood.V128.22.995.995
Published: 2016
Journal Articles

Triplet vs doublet lenalidomide-containing regimens for the treatment of elderly patients with newly diagnosed multiple myeloma

Clinical Trials & Observations
Valeria Magarotto, Sara Bringhen, Massimo Offidani, Giulia Benevolo, Francesca Patriarca, Roberto Mina, Antonietta Pia Falcone, Lorenzo De Paoli, Giuseppe Pietrantuono, Silvia Gentili, Caterina Musolino, Nicola Giuliani, Annalisa Bernardini, Concetta Conticello, Stefano Pulini, Giovannino Ciccone, Vladimír Maisnar, Marina Ruggeri, Renato Zambello, Tommasina Guglielmelli, Antonio Ledda, Anna Marina Liberati, Vittorio Montefusco, Roman Hajek, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2016) 127 (9): 1102–1108.
https://doi.org/10.1182/blood-2015-08-662627
Published: 2016
Includes: Supplemental data
Journal Articles

Significant Survival Improvement with Maintenance in Patients Achieving a Complete Response: Pooled Analysis of 4 Italian Phase III Trials in Newly Diagnosed Multiple Myeloma Patients

Chiara Cerrato, Francesca Gay, Maria Teresa Petrucci, Pellegrino Musto, Gianluca Gaidano, Massimo Offidani, Tommasina Guglielmelli, Marco Salvini, Francesca Patriarca, Elena Ponticelli, Gianpietro Semenzato, Francesco Di Raimondo, Roberto Mina, Nicola Cascavilla, Dina Ben Yehuda, Daniela Oddolo, Paolo Corradini, Lucio Catalano, Paolo Di Bartolomeo, Roman Hájek, Andrew Spencer, Mario Boccadoro, MD, Antonio Palumbo
Journal: Blood
Blood (2015) 126 (23): 1974.
https://doi.org/10.1182/blood.V126.23.1974.1974
Published: 2015
Journal Articles

Minimal Residual Disease Monitoring During Maintenance In Multiple Myeloma Patients

Alberto Rocci, Manuela Gambella, Paola Omedè, PhD, Daniela Drandi, Francesca Gay, Francesca Patriarca, MD, Federica Cavallo, Maria Teresa Petrucci, MD, Caravita Tommaso, Giulia Benevolo, Norbert Pescosta, MD, Stefania Oliva, Massimo Offidani, Vittorio Montefusco, Anna Marina Liberati, Antonietta Pia Falcone, MD, Stelvio Ballanti, Tonino Spadano, MD, Tommasina Guglielmelli, Pellegrino Musto, MD, Renato Zambello, MD, Francesco Di Raimondo, MD, Marco Ladetto, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 3126.
https://doi.org/10.1182/blood.V122.21.3126.3126
Published: 2013
Journal Articles

Long-Term Molecular Results Of The Gimema VEL-03-096 Trial: Molecular Remission Achievement and Loss Are Major Outcome Predictors

Simone Ferrero, Marco Ladetto, Daniela Drandi, Federica Cavallo, Elisa Genuardi, Marina Urbano, Guglielmo Guarona, Vincenzo Callea, Clotilde Cangialosi, Tommaso Caravita, MD, Claudia Crippa, MD, Luca De Rosa, Antonietta Pia Falcone, MD, Mariella Grasso, Tommasina Guglielmelli, Anna Marina Liberati, Francesco Pisani, Patrizia Pregno, Fausto Rossini, MD, Stefania Oliva, Alberto Rocci, Roberto Passera, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 2077.
https://doi.org/10.1182/blood.V122.21.2077.2077
Published: 2013
Journal Articles

Reduced Dose-Intensity Subcutaneous Bortezomib Plus Prednisone (VP) Or Plus Cyclophosfamide (VCP) Or Plus Melphalan (VMP) For Newly Diagnosed Multiple Myeloma Patients Older Than 75 Years Of Age

Alessandra Larocca, MD, Federica Cavallo, MD, Valeria Magarotto, MD, Massimo Offidani, MD, Vincenzo Federico, MD, Vanessa Innao, MD, Antonietta Pia Falcone, MD, Alessandra Romano, MD, Tommaso Caravita, MD, Davide Rossi, MD, Giovanna Mansueto, MD, Roberto Mina, MD, Chiara Nozzoli, MD, Giulia Benevolo, MD, Tommasina Guglielmelli, MD, Anna Marina Liberati, MD, Daniele Derudas, MD, Stefania Oliva, Fortunato Morabito, MD, Angelo Michele Carella, MD, Silvia Gentili, MD, Elona Saraci, Maria Teresa Petrucci, MD, Pieter Sonneveld, MD, Ph.D, Mario Boccadoro, MD, Antonio Palumbo, MD
Journal: Blood
Blood (2013) 122 (21): 539.
https://doi.org/10.1182/blood.V122.21.539.539
Published: 2013
Journal Articles

Pomalidomide, cyclophosphamide, and prednisone for relapsed/refractory multiple myeloma: a multicenter phase 1/2 open-label study

Clinical Trials & Observations
Alessandra Larocca, Vittorio Montefusco, Sara Bringhen, Davide Rossi, Claudia Crippa, Roberto Mina, Monica Galli, Magda Marcatti, Giacinto La Verde, Nicola Giuliani, Valeria Magarotto, Tommasina Guglielmelli, Delia Rota-Scalabrini, Paola Omedé, Alberto Santagostino, Ileana Baldi, Angelo Michele Carella, Mario Boccadoro, Paolo Corradini, Antonio Palumbo
Journal: Blood
Blood (2013) 122 (16): 2799–2806.
https://doi.org/10.1182/blood-2013-03-488676
Published: 2013
Includes: Supplemental data
Journal Articles

Bortezomib induction, reduced-intensity transplantation, and lenalidomide consolidation-maintenance for myeloma: updated results

Clinical Trials & Observations
Francesca Gay, Valeria Magarotto, Claudia Crippa, Norbert Pescosta, Tommasina Guglielmelli, Federica Cavallo, Sara Pezzatti, Samantha Ferrari, Anna Marina Liberati, Stefania Oliva, Francesca Patriarca, Massimo Offidani, Paola Omedé, Vittorio Montefusco, Maria Teresa Petrucci, Nicola Giuliani, Roberto Passera, Giuseppe Pietrantuono, Mario Boccadoro, Paolo Corradini, Antonio Palumbo
Journal: Blood
Blood (2013) 122 (8): 1376–1383.
https://doi.org/10.1182/blood-2013-02-483073
Published: 2013
Includes: Supplemental data
Journal Articles

Pomalidomide Cyclophosphamide and Prednisone (PCP) Treatment for Relapsed/Refractory Multiple Myeloma

Antonio Palumbo, MD, Alessandra Larocca, MD, Vittorio Montefusco, Davide Rossi, MD, PhD, Angelo Michele Carella, MD, Roberto Mina, MD, Claudia Crippa, MD, Mariella Sciacca, MD, Monica Galli, MD, Delia Rota Scalabrini, MD, Magda Marcatti, MD, Tommasina Guglielmelli, MD, Nicola Giuliani, Giacinto La Verde, MD, Ileana Baldi, MD, Vittorio Emanuele Muccio, Mario Boccadoro, MD, Paolo Corradini, MD
Journal: Blood
Blood (2012) 120 (21): 446.
https://doi.org/10.1182/blood.V120.21.446.446
Published: 2012
Journal Articles

Overall Survival Benefit for Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance with Bortezomib-Thalidomide (VMPT-VT) Versus Bortezomib-Melphalan-Prednisone (VMP) in Newly Diagnosed Multiple Myeloma Patients

Antonio Palumbo, MD, Sara Bringhen, Davide Rossi, MD, Maide Cavalli, MD, Roberto Ria, MD, Silvia Gentilini, MD, Francesca Patriarca, Chiara Nozzoli, MD, Anna Levi, MD, Tommasina Guglielmelli, MD, Giulia Benevolo, MD, Donatella Vincelli, MD, Luca Baldini, Fortunato Morabito, MD, Mariella Grasso, MD, Roberto Marasca, MD, Manuela Rizzo, MD, Chiara Pautasso, Pharm D, Antonietta Pia Falcone, MD, Daniela Gottardi, MD, Vittorio Montefusco, MD, Caterina Musolino, MD, Clotilde Cangialosi, MD, Giovanna Mansueto, MD, Anna Marina Liberati, MD, Valeria Magarotto, MD, Paola Omedè, PhD, Pellegrino Musto, MD, Maria Teresa Petrucci, MD, Mario Boccadoro, MD
Journal: Blood
Blood (2012) 120 (21): 200.
https://doi.org/10.1182/blood.V120.21.200.200
Published: 2012
Journal Articles

Cytoplasmic-Nuclear Shuttling of mTOR Protein in Multiple Myeloma Cell Lines and Primary Myeloma Cells: A New Mechanism Regulated by Pomalidomide

Tommasina Guglielmelli, MD, Emilia Giugliano, PhD, Vanessa Brunetto, PhD, Sokol Rrodhe, MD, Giuseppe Saglio, MD
Journal: Blood
Blood (2012) 120 (21): 4019.
https://doi.org/10.1182/blood.V120.21.4019.4019
Published: 2012
Journal Articles

Safety and efficacy of bortezomib-melphalan-prednisone-thalidomide followed by bortezomib-thalidomide maintenance (VMPT-VT) versus bortezomib-melphalan-prednisone (VMP) in untreated multiple myeloma patients with renal impairment

Clinical Trials & Observations
Fortunato Morabito, Massimo Gentile, Carla Mazzone, Davide Rossi, Francesco Di Raimondo, Sara Bringhen, Roberto Ria, Massimo Offidani, Francesca Patriarca, Chiara Nozzoli, Maria Teresa Petrucci, Giulia Benevolo, Iolanda Vincelli, Tommasina Guglielmelli, Mariella Grasso, Roberto Marasca, Luca Baldini, Vittorio Montefusco, Pellegrino Musto, Nicola Cascavilla, Ignazio Majolino, Caterina Musolino, Michele Cavo, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2011) 118 (22): 5759–5766.
https://doi.org/10.1182/blood-2011-05-353995
Published: 2011
Journal Articles

A Phase I/II Study of Pomalidomide-Cyclophosphamide-Prednisone (PCP) in Patients with Multiple Myeloma Relapsed/Refractory to Lenalidomide

Antonio Palumbo, MD, Alessandra Larocca, MD, Angelo Michele Carella, MD, Davide Rossi, Vittorio Montefusco, MD, Samantha Ferrari, MD, Alberto Santagostino, MD, Tommasina Guglielmelli, MD, Monica Galli, MD, Antonio Capaldi, MD, Nicola Giuliani, M.D., Ph.D., Giacinto La Verde, Paola Omedè, MD, Ileana Baldi, Mario Boccadoro, MD, Paolo Corradini, MD
Journal: Blood
Blood (2011) 118 (21): 632.
https://doi.org/10.1182/blood.V118.21.632.632
Published: 2011
Journal Articles

LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVAL

Marco Ladetto, MD, Simone Ferrero, Daniela Drandi, PhD, Federica Cavallo, Luigia Monitillo, Paola Ghione, Sara Barbiero, Mariella Grasso, Fausto Rossini, MD, Tommasina Guglielmelli, MD, Clotilde Cangialosi, MD, Anna Marina Liberati, MD, Vincenzo Callea, MD, Tommaso Caravita, MD, Luca De Rosa, MD, Francesco Pisani, Antonietta Pia Falcone, Patrizia Pregno, MD, Alberto Rocci, Roberto Passera, Mario Boccadoro, Antonio Palumbo, MD
Journal: Blood
Blood (2011) 118 (21): 827.
https://doi.org/10.1182/blood.V118.21.827.827
Published: 2011
Journal Articles

Efficacy and safety of once-weekly bortezomib in multiple myeloma patients

Clinical Trials & Observations
Sara Bringhen, Alessandra Larocca, Davide Rossi, Maide Cavalli, Mariella Genuardi, Roberto Ria, Silvia Gentili, Francesca Patriarca, Chiara Nozzoli, Anna Levi, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, Vincenzo Rizzo, Clotilde Cangialosi, Pellegrino Musto, Luca De Rosa, Anna Marina Liberati, Mariella Grasso, Antonietta P. Falcone, Andrea Evangelista, Michele Cavo, Gianluca Gaidano, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (23): 4745–4753.
https://doi.org/10.1182/blood-2010-07-294983
Published: 2010
Journal Articles

Targeting TORC2 in multiple myeloma with a new mTOR kinase inhibitor

Bao Hoang, Patrick Frost, Yijiang Shi, Eileen Belanger, Angelica Benavides, Gholam Pezeshkpour, Susanna Cappia, Tommasina Guglielmelli, Joseph Gera, Alan Lichtenstein
Journal: Blood
Blood (2010) 116 (22): 4560–4568.
https://doi.org/10.1182/blood-2010-05-285726
Published: 2010
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Once Weekly Bortezomib In Multiple Myeloma Patients

Sara Bringhen, Alessandra Larocca, Davide Rossi, Alessandra Romano, Mariella Genuardi, Roberto Ria, Pietro Leoni, Francesca Patriarca, Chiara Nozzoli, Tommasina Guglielmelli, Giulia Benevolo, Vincenzo Callea, MD, Fabiana Gentilini, Francesca Elice, Barbara Olivero, Mariella Grasso, Antonietta Pia Falcone, Daniela Gottardi, Vittorio Montefusco, Alessandro Allegra, Manuela Rizzo, Giovanna Leonardi, Daniela Oddolo, Fortunato Morabito, Mario Boccadoro, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 3029.
https://doi.org/10.1182/blood.V116.21.3029.3029
Published: 2010
Journal Articles

Achievement of Complete Response Is a Strong Prognostic Factor In Elderly Newly Diagnosed Myeloma: Retrospective Analysis of 1175 Patients

Francesca Gay, Alessandra Larocca, P.W. Wijermans, Sara Bringhen, Tommasina Guglielmelli, Martijn R. Schaafsma, Giulia Benevolo, Vincenzo Callea, Luca Baldini, Fortunato Morabito, Mariella Grasso, Giuseppe Torelli, Manuela Rizzo, Monica Galli, Grazia Sanpaolo, Clotilde Cangialosi, Paola Omedè, Mario Boccadoro, Pieter Sonneveld, Antonio Palumbo
Journal: Blood
Blood (2010) 116 (21): 1949.
https://doi.org/10.1182/blood.V116.21.1949.1949
Published: 2010